Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | FLX475 |
Synonyms | |
Therapy Description |
FLX475 is a CCR4 antagonist, which potentially results in increased effector T-cell and decreased regulatory T-cells within the tumor microenvironment, leading to antitumor activity (Journal for ImmunoTherapy of Cancer 2022;10). |